Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation
Open Access

18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma

Xiang Li, Na Lu, Lili Lin, Yiwen Chen, Shuye Yang, Huatao Wang, Xinyuan Liu, Chengyi Wu, Xing Xue, Xinhui Su, Xueli Bai and Tingbo Liang
Journal of Nuclear Medicine February 2024, 65 (2) 206-212; DOI: https://doi.org/10.2967/jnumed.123.266283
Xiang Li
1Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
2Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Na Lu
1Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
2Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lili Lin
3Department of Nuclear Medicine, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yiwen Chen
1Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
2Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shuye Yang
3Department of Nuclear Medicine, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Huatao Wang
3Department of Nuclear Medicine, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinyuan Liu
1Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
2Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chengyi Wu
1Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
2Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xing Xue
4Department of Radiology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinhui Su
3Department of Nuclear Medicine, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xueli Bai
1Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
2Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tingbo Liang
1Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
2Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China;
5Zhejiang University Cancer Center, Hangzhou, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. 2 206-212
DOI 
https://doi.org/10.2967/jnumed.123.266283
PubMed 
38176719

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication July 21, 2023
  • Revision received November 7, 2023
  • Published online February 1, 2024.

Article Versions

  • previous version (January 4, 2024 - 06:54).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.

Author Information

  1. Xiang Li*,1,2,
  2. Na Lu*,1,2,
  3. Lili Lin3,
  4. Yiwen Chen1,2,
  5. Shuye Yang3,
  6. Huatao Wang3,
  7. Xinyuan Liu1,2,
  8. Chengyi Wu1,2,
  9. Xing Xue4,
  10. Xinhui Su3,
  11. Xueli Bai†,1,2 and
  12. Tingbo Liang†,1,2,5
  1. 1Department of Hepatobiliary and Pancreatic Surgery, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
  2. 2Zhejiang Provincial Key Laboratory of Pancreatic Disease, Hangzhou, China;
  3. 3Department of Nuclear Medicine, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China;
  4. 4Department of Radiology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China; and
  5. 5Zhejiang University Cancer Center, Hangzhou, China
  1. For correspondence or reprints, contact Tingbo Liang (liangtingbo{at}zju.edu.cn) or Xueli Bai (shirleybai{at}zju.edu.cn).
View Full Text

Statistics from Altmetric.com

Cited By...

  • 18 Citations
  • 16 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Cancer-Associated Fibroblasts in Pancreatic Ductal Adenocarcinoma or a Metaphor for Heterogeneity: From Single-Cell Analysis to Whole-Body Imaging
    Rita Saúde-Conde, Ayça Arçay Öztürk, Kosta Stosic, Oier Azurmendi Senar, Julie Navez, Christelle Bouchart, Tatjana Arsenijevic, Patrick Flamen, Jean-Luc Van Laethem
    Biomedicines 2024 12 3
  • Comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT in Fumarate Hydratase-Deficient Renal Cell Carcinoma
    Shuhui Huang, Haoyang Liu, Hongyuan Dai, Mengfang Qi, Minggang Su, Hao Zeng, Rui Huang
    Clinical Nuclear Medicine 2024 49 10
  • Elevated protein lactylation promotes immunosuppressive microenvironment and therapeutic resistance in pancreatic ductal adenocarcinoma
    Kang Sun, Xiaozhen Zhang, Jiatao Shi, Jinyan Huang, Sicheng Wang, Xiang Li, Haixiang Lin, Danyang Zhao, Mao Ye, Sirui Zhang, Li Qiu, Minqi Yang, Chuyang Liao, Lihong He, Mengyi Lao, Jinyuan Song, Na Lu, Yongtao Ji, Hanshen Yang, Lingyue Liu, Xinyuan Liu, Yan Chen, Shicheng Yao, Qianhe Xu, Jieru Lin, Yan Mao, Jingxing Zhou, Xiao Zhi, Ke Sun, Xiongbin Lu, Xueli Bai, Tingbo Liang
    Journal of Clinical Investigation 2025 135 7
  • Development and Preclinical Evaluation of 18F-Labeled PEGylated Sansalvamide A Decapeptide for Noninvasive Evaluation of Hsp90 Status in Pancreas Cancer
    Xiaohui Wang, Zhijian Han, Jun Zhang, Ming Chen, Wenbo Meng
    Molecular Pharmaceutics 2024 21 10
  • The Role of FAPI PET Imaging in Pancreatic Cancer: A Meta-analysis Compared with 18F-FDG PET
    Xianwen Hu, Xiaotian Li, Pan Wang, Jiong Cai
    Academic Radiology 2025 32 1
  • Value of [18F]AlF-NOTA-FAPI-04 PET/CT for predicting pathological response and survival in patients with locally advanced pancreatic ductal adenocarcinoma receiving neoadjuvant chemotherapy
    Yafei Zhang, Mimi Xu, Yu Wang, Fang Yu, Xinxin Chen, Guangfa Wang, Kui Zhao, Hong Yang, Xinhui Su
    European Journal of Nuclear Medicine and Molecular Imaging 2025 52 6
  • 18F-AlF-NOTA-FAPI-04 Superior to 18F-FDG PET/CT in Detecting Primary Tumor and Metastatic Lymph Nodes in a Cervical Cancer Patient
    Jinhui Wei, Qiaochu Feng, Haodong Liu, Hongna Zheng, Longjie Li
    Clinical Nuclear Medicine 2025 50 2
  • 64Cu Radiolabeled PDGFRβ-Targeting Affibody for PET Imaging in Pancreatic Cancer
    Zhao Li, Ruiman Geng, Yousheng Zhan, Ruomeng Liu, Mufeng Li, Nengwen Ke, Hao Yang, Xiaofeng Lu, Lin Li, Suping Li, Huawei Cai
    Molecular Pharmaceutics 2025 22 3
  • Clinical Utility of 18Fluorine‐Fibroblast Activation Protein Inhibitor‐04 Positron Emission Tomography/Computed Tomography in the Evaluation of Pancreatic Ductal Adenocarcinoma: Comparison With 18Fluorine‐Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography
    Lili Lin, Guangfa Wang, Yafei Zhang, Guolin Wang, Kui Zhao, Xinhui Su
    MedComm 2025 6 3
  • Clinical significance of diffuse [18F] AlF-NOTA-FAPI-04 uptake in the thyroid on PET/CT imaging
    Ying Kou, Wei Diao, Zhuzhong Cheng, Yutang Yao
    EJNMMI Research 2025 15 1

Article usage

Article usage: January 2024 to April 2025

AbstractFullPdf
Jan 2024363578220
Feb 2024708521167
Mar 2024227357185
Apr 2024170236104
May 202411017376
Jun 20248621883
Jul 20244933492
Aug 20244525174
Sep 2024479783
Oct 20243413068
Nov 20245315789
Dec 202440196117
Jan 202535176107
Feb 20251723480
Mar 202528170118
Apr 20253118098
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (2)
Journal of Nuclear Medicine
Vol. 65, Issue 2
February 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma
Xiang Li, Na Lu, Lili Lin, Yiwen Chen, Shuye Yang, Huatao Wang, Xinyuan Liu, Chengyi Wu, Xing Xue, Xinhui Su, Xueli Bai, Tingbo Liang
Journal of Nuclear Medicine Feb 2024, 65 (2) 206-212; DOI: 10.2967/jnumed.123.266283

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
18F-FAPI-04 Outperforms 18F-FDG PET/CT in Clinical Assessments of Patients with Pancreatic Adenocarcinoma
Xiang Li, Na Lu, Lili Lin, Yiwen Chen, Shuye Yang, Huatao Wang, Xinyuan Liu, Chengyi Wu, Xing Xue, Xinhui Su, Xueli Bai, Tingbo Liang
Journal of Nuclear Medicine Feb 2024, 65 (2) 206-212; DOI: 10.2967/jnumed.123.266283
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

Keywords

  • 18F-FAPI-04
  • 18F-FDG
  • PET/CT
  • pancreatic ductal adenocarcinoma
  • staging
SNMMI

© 2025 SNMMI

Powered by HighWire